Tavita

The GLP-1 Nutrition Gap: What 461,382 Patient Records Actually Show

In a peer-reviewed analysis of 461,382 adults, 22.4% had a nutritional deficiency diagnosed within a year of starting a GLP-1. Vitamin D led, protein is the bigger gap, and the hair-loss evidence points somewhere other than vitamins.

Marquis Mendoza10 min read
Flat illustration of a small plate beside the fuller meal it replaced, with protein and produce shown separately as the foods most easily crowded out

Researchers followed the claims records of 461,382 adults who started a GLP-1 medication. Within twelve months, 22.4 percent had a nutritional deficiency formally diagnosed. Vitamin D accounted for most of it, and three percent were diagnosed with muscle loss inside the same year.

That is not a figure from a supplement company. It is a peer-reviewed retrospective analysis, and it is the closest thing we have to a real denominator for a question millions of people are now asking.

22.4%had a nutritional deficiency diagnosed within 12 months
13.6%were diagnosed low in vitamin D — the commonest single finding
461,382adults in the analysis
What was diagnosed in the first year on a GLP-1These are recorded diagnoses, not screening results — everyone here was tested for a reason. Muscle loss was reported only as a within-one-year figure.
0%5%10%15%20%25%Any nutritional deficiency: 12.7% within 6 months, 22.4% within 12 monthsAny nutritional deficiency12.7%22.4%Vitamin D deficiency: 7.5% within 6 months, 13.6% within 12 monthsVitamin D deficiency7.5%13.6%Nutritional anaemia: 2.1% within 6 months, 4% within 12 monthsNutritional anaemia2.1%4%Muscle loss: 3% within 12 monthsMuscle loss3%
View the data as a table
DiagnosisWithin 6 monthsWithin 12 months
Any nutritional deficiency12.7%22.4%
Vitamin D deficiency7.5%13.6%
Nutritional anaemia2.1%4%
Muscle lossNot reported3%

Source: Butsch WS, Sulo S, Chang AT, et al. Obesity Pillars 2025;15:100186. Retrospective analysis of de-identified claims for 461,382 adults newly prescribed a GLP-1 receptor agonist, July 2017 to December 2021.

Free to reuse with credit.

What the study measured — and why the real number is probably higher

The analysis, published in Obesity Pillars by Butsch and colleagues, covered adults with type 2 diabetes newly prescribed a GLP-1 receptor agonist between July 2017 and December 2021, compared against propensity-matched patients on metformin alone. At twelve months the GLP-1 group had higher rates of deficiency, particularly vitamin D and the B vitamins.

Now the detail that changes how you should read the headline. Patients who saw a dietitian within six months were diagnosed with deficiencies more often, not less — 18.5 percent versus 12.2 percent, and 29.8 versus 21.8 percent at a year.

The people who got looked at were the people who got found. Everyone else was simply never tested.

A dietitian visit does not cause a deficiency. It causes the deficiency to be noticed. Every number in that chart is a recorded diagnosis, which means somebody ordered a test, which means 22.4 percent is a floor rather than a ceiling. The quiet implication is that if you are on a GLP-1 and nobody has checked your bloods, you are not in the reassuring group — you are in the untested one.

Does the drug deplete vitamins, or does eating less?

This distinction matters, because the answer determines what actually helps.

GLP-1 receptor agonists slow gastric emptying and blunt appetite. There is no established mechanism by which they bind, chelate, or destroy micronutrients. The plausible route to a deficiency is much more ordinary: you eat considerably less food for months, and food is where nutrients come from. Nausea and food aversions narrow the diet further, often away from exactly the foods that carry the most nutrition per bite.

It is worth being precise about the limits here. This was an observational analysis of claims data. It establishes that deficiencies were diagnosed more often in GLP-1 users than in matched controls. It does not establish the mechanism, and no honest reading of it can.

Illustration of a much smaller meal beside the fuller plate it replaced, with the nutrient-dense foods that were crowded out shown separately
A smaller appetite does not shrink every food group evenly — protein and produce tend to go first.

The bigger gap, and nobody is selling a gummy for it

The search results for GLP-1 nutrition are almost entirely about micronutrients, because micronutrients are what there is a product to sell. The larger problem is more boring.

In a cross-sectional study of GLP-1 users, only 43 percent reached 1.2 grams of protein per kilogram of body weight per day — the lower bound of what is generally advised during active weight loss. Ten percent reached 1.6 g/kg. Five percent reached 2.0.

How many GLP-1 users actually hit a protein targetThresholds are cumulative — anyone meeting 2.0 g/kg also meets 1.2 — so these are nested shares, not slices of a whole. Small study: 60 adults.
0%25%50%75%100%43% of users reached 1.2 g/kg per day1.2 g/kglower end of guidance43%10% of users reached 1.6 g/kg per day1.6 g/kgmid-range10%5% of users reached 2.0 g/kg per day2.0 g/kgupper end5%
View the data as a table
Daily protein thresholdShare of users meeting it
1.2 g/kg of body weight43%
1.6 g/kg of body weight10%
2.0 g/kg of body weight5%

Source: Johnson B, McGlasson T, Thomas O, Kreider R, Jones R. Journal of the International Society of Sports Nutrition 2025;22(Suppl 2):2550139. Cross-sectional survey of 60 adults using GLP-1 receptor agonists.

Free to reuse with credit.

That study is small — 60 adults — and it was published in a conference supplement, so treat the exact percentages as indicative rather than settled. The direction, though, lines up with the muscle-loss finding in the much larger claims analysis, where three percent of patients received a muscle-loss diagnosis within a year. A formal diagnosis is a high bar; the number of people quietly losing lean tissue without one is necessarily larger.

Protein is also the one variable here you can move immediately, without a blood test, a prescription, or a purchase.

Why hair loss is not the vitamin story it is sold as

Hair loss is one of the most searched GLP-1 side effects, and an entire product category has grown up around it. The evidence supports the side effect. It does not support the product.

A scoping review of alopecia associated with GLP-1 receptor agonists collected the trial-level reports: around 7 percent of participants in SURMOUNT-3 (20 of 287) and a similar share in OASIS 1 (23 of 334). The FDA adverse event system holds more than a thousand spontaneous reports, though the review is careful to note that spontaneous reporting cannot produce a real incidence rate.

The mechanism the reviewers put forward is not a nutrient deficiency. It is rapid weight loss itself — acute metabolic stress triggering telogen effluvium, the same temporary shedding well documented after bariatric surgery, serious illness, and aggressive calorie restriction. Of the 35 cases characterised in detail, 19 were androgenetic and 10 were telogen effluvium, suggesting GLP-1s may also unmask pattern hair loss in people already predisposed.

What this does and does not mean

Telogen effluvium is usually self-limiting: it follows the trigger by roughly three months and resolves as the follicle cycle normalises. No trial has shown that a vitamin supplement prevents or reverses GLP-1-associated hair loss. What the evidence does support is unglamorous — adequate protein and adequate iron are genuine requirements for hair growth, and they are the part of this you can influence. Persistent or patchy loss deserves a dermatologist, not a gummy.

What not to take together

One PAA question that comes up constantly is what not to take alongside a GLP-1. The honest answer is that the sharper conflicts are usually between your supplements, not between a supplement and the drug.

Calcium and iron compete directly, and taking them together substantially reduces iron absorption — which matters more than usual if hair thinning is already a worry. Vitamin D is fat-soluble and does better with a meal containing some fat, which is a real constraint when meals have become small and low-fat by accident. And because GLP-1s slow gastric emptying, anything taken with food sits longer before it is absorbed. You can check a specific combination in our supplement stack checker, and the nutrient pairings pages cover the individual conflicts.

What to actually do about it

  1. Ask for bloods rather than guessingVitamin D, B12, ferritin and a full blood count are inexpensive and they replace speculation with a number. Given that the diagnosed rate rose sharply among people who were actually assessed, this is the single highest-value step — and it is the one no supplement bundle can do for you.
  2. Put protein first in the meal, literallyWhen appetite is suppressed, the first few bites are the only ones you are guaranteed to finish. Work out your target in grams — 1.2 g/kg as a floor — and eat that part of the plate first.
  3. Treat vitamin D as the likeliest gapIt was the most frequently diagnosed deficiency by a wide margin. Take it with the fattiest meal of your day, and confirm the dose against a test rather than a label.
  4. Add resistance training if you canProtein preserves lean mass considerably better when there is a reason for the body to keep it. Only about half of GLP-1 users in that survey reported exercising more after starting.
  5. Track density, not just caloriesA 1,200-calorie day can be nutritionally excellent or nutritionally empty, and the calorie total cannot tell them apart. When you are eating half as much, what each meal contains stops being a detail.

That last one is the whole reason Tavita exists — it shows the micronutrients under a meal, not just the calorie total on top of it.

Where Tavita fits, and where it does not

Tavita will show you what your intake actually looks like against reference amounts — the protein target in grams, and where vitamin D, iron and B12 are running against them. On a GLP-1, where intake drops sharply and quietly, that visibility is the difference between noticing a gap in week three and being diagnosed with one in month nine.

What it will not do is measure your blood. A food log is an estimate of intake, not of status, and the two come apart — particularly for vitamin D, where sun exposure and absorption matter as much as diet. Nothing here replaces a test or your prescriber. It tells you where to look.

Common questions

Does Ozempic deplete any vitamins?

Not in the sense of the drug binding or destroying nutrients. GLP-1 medications work by slowing gastric emptying and reducing appetite, so the plausible route to a deficiency is simply eating less of everything for months. The large claims analysis found that 22.4 percent of users had a nutritional deficiency diagnosed within a year, with vitamin D the most common — but an observational study shows association, not mechanism.

Do I need to take B12 with Ozempic?

Not automatically. B-vitamin deficiencies were more common in GLP-1 users than in matched metformin-only controls in the 2025 claims analysis, but that is a population signal, not a prescription for you. B12 status is a cheap blood test, and testing tells you something guessing cannot. If you are also on metformin, which has a well-established association with low B12, that is a specific reason to ask about testing.

What vitamins should not be taken with Ozempic?

The bigger practical issue is not the medication but the supplements interacting with each other. Calcium blocks iron absorption when the two are taken together, and iron is absorbed best away from food, which is awkward when you are eating little. Because GLP-1s slow gastric emptying, anything you take with a meal sits longer before absorption. Space iron and calcium by a couple of hours, and raise anything new with your prescriber and pharmacist.

What vitamins should I take while on Zepbound?

The evidence base does not separate tirzepatide from semaglutide on nutritional status — the deficiency data covers GLP-1 receptor agonists as a class. The sensible approach is identical: test rather than guess, prioritise protein, and treat vitamin D as the most likely gap because it was the most frequently diagnosed one.

What organ is Ozempic hard on?

That is a prescriber question rather than a nutrition one, and the honest answer is that it belongs with the labelled adverse reactions and your doctor rather than with a food log. Nothing in the nutritional data speaks to organ safety, and we are not going to extrapolate from one to the other.

See what a smaller appetite is costing you

Tavita tracks the micronutrients and protein under every meal, not just the calories — and flags supplement timing and interactions alongside them.

Get Tavita

Free to try. Or browse the nutrient reference library first.

Sources and corrections

Every figure here is attributed to the study it came from, and we flag sample size and study design where they limit how much weight a number can carry. If you believe something is inaccurate, email support@tavita.app and we will correct it promptly. This article is general information, not medical advice — decisions about your medication, testing, or supplementation belong with your prescriber.

  1. Butsch WS, Sulo S, Chang AT, et al. Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study. Obesity Pillars 2025;15:100186.
  2. Johnson B, McGlasson T, Thomas O, Kreider R, Jones R. Suboptimal protein intake for hypocaloric diet needs while using glucagon-like peptide-1 receptor agonists. Journal of the International Society of Sports Nutrition 2025;22(Suppl 2):2550139.
  3. Alopecia as an emerging adverse effect associated with glucagon-like peptide-1 receptor agonists for weight loss: a scoping review. PMC12431796.